Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion type Assertion NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_head.
- NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion description "[Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_provenance.
- NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion evidence source_evidence_literature NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_provenance.
- NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion SIO_000772 19365520 NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_provenance.
- NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion wasDerivedFrom befree-2016 NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_provenance.
- NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_assertion wasGeneratedBy ECO_0000203 NP732254.RAaR8VDzeYCKR6M7djzdXLe3d1qTpsxjhrvDXs2qc_X_4130_provenance.